Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency - Top-Institutions - MDSpire

Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency

  • By

  • Lizzy Lawrence

  • March 6, 2026

  • 0 min

Share

Top Institutions in General Medicine

Brief introduction explaining scope and methodology.

  • #1

    Food and Drug Administration (FDA)
    Food and Drug Administration (FDA)

    Silver Spring, MD

    Key Differentiators

    • Regulatory Science
    • Drug Evaluation
    • Clinical Trial Oversight

  • #2

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Clinical Trial Design
    • Oncology
    • Translational Medicine

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Regulatory Science
    • Clinical Pharmacology
    • Drug Development

  • #4

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Clinical Research
    • Regulatory Affairs
    • Gene Therapy

  • #5

    Duke University
    Duke University

    Durham, NC

    Key Differentiators

    • Clinical Trial Innovation
    • Regulatory Science
    • Rare Diseases

Original Source(s)

Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency

  • by Lizzy Lawrence

  • March 6, 2026

Related Content

Using GPT-4 to annotate the severity of all phenotypic abnormalities within the human phenotype ontology

Efficacy of a Single Dose of Albendazole for Treating Ascaris lumbricoides in Schoolchildren in Northwest Ethiopia: An Open-Label Trial Examining Re-Infection Rates and Contributing Factors

Maternal and Pediatric Use of Vaccines for Mpox: A Living Systematic Review and Meta-analysis of Safety and Effectiveness